J.P. Morgan Sticks to Its Hold Rating for Pembina Pipeline (PBA)
In a report released on March 28, Jeremy Tonet from J.P. Morgan maintained a Hold rating on Pembina Pipeline (PBA – Research Report), with a ...
Microbiome Disease Pipeline Insight 2025: Over 180 Drugs in Development Across 140+ Companies
The Microbiome Disease Pipeline Report 2025 reveals 180+ drugs under development across 140+ companies, covering late-stage, mid-stage, and early-stage therapies. Major players such as MaaT Pharma, ...